Research Topics
Species | Matteo MonamiSummaryCountry: Italy Publications
| Collaborators
|
Detail Information
Publications
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trialsM Monami
Section of Geriatric Cardiology and Medicine, Careggi Teaching Hospital, Florence, Italy
Diabetes Obes Metab 15:112-20. 2013..The present meta-analysis is aimed at verifying this protective effect, collecting all available data from randomized trials...
Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trialsMatteo Monami
Geriatric Cardiology, Azienda Ospedaliero Universitaria Careggi, Careggi Teaching Hospital and University of Florence, Via delle Oblate 4, Florence, Italy
Adv Ther 29:736-46. 2012..The present meta-analysis was designed to assess the effect of DPP-4 inhibitors, pioglitazone, insulin secretagogs, and acarbose on blood lipids when compared to placebo...
Skin autofluorescence in type 2 diabetes: beyond blood glucoseMatteo Monami
Department of Critical Care Medicine and Surgery, Geriatric Unit, University of Florence and AOU Careggi, Florence, Italy
Diabetes Res Clin Pract 79:56-60. 2008..Aim of this study is the assessment of parameters associated with increased AF in a sample of type 2 diabetic patients...
Pulse pressure and prediction of incident foot ulcers in type 2 diabetesMatteo Monami
Department of Cardiovascular Medicine, University of Florence and Azienda Ospedaliera Careggi, Florence, Italy
Diabetes Care 32:897-9. 2009..To assess the relevance of pulse pressure as a predictor of foot ulcers in type 2 diabetic subjects...
Are comorbidity indices useful in predicting all-cause mortality in Type 2 diabetic patients? Comparison between Charlson index and disease countMatteo Monami
Unit of Gerontology and Geriatrics, Department of Critical Care Medicine and Surgery, University of Firenze, Firenze, Italy
Aging Clin Exp Res 19:492-6. 2007..The aim of the present study was to compare the predictive value of disease count and Charlson's Comorbidity Index (CCI) for 3-year mortality in type 2 diabetic (T2D) patients...
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control studyMatteo Monami
Department of Critical Care Medicine and Surgery, Unit of Geriatrics, University of Florence and Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, 50134 Florence, Italy
Diabetes Care 31:199-203. 2008..The aim of this case-control study, nested within a retrospective cohort, is the assessment of the risk for bone fractures associated with exposure to insulin or different oral hypoglycemic agents...
Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysisMatteo Monami
Department of Critical Care Medicine and Surgery, Unit of Geriatrics, University of Florence and Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, 50134 Florence, Italy
Diabetes Res Clin Pract 79:196-203. 2008..Aim of the present meta-analysis is to collect available information on the efficacy of different hypoglycemic drugs, in combination with metformin, in patients failing to metformin, or to other oral monotherapies...
Prognostic value of International Diabetes Federation and Adult Treatment Panel III definitions of metabolic syndrome in Type 2 diabetic patients: what makes the difference?M Monami
Unit of Gerontology and Geriatrics, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy
J Endocrinol Invest 30:626-30. 2007....
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysisM Monami
Section of Geriatric Cardiology, Department of Cardiovascular Medicine, Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, Florence, Italy
Exp Clin Endocrinol Diabetes 117:220-2. 2009..Continuous Subcutaneous Insulin Infusion (CSII) improves HbA1c in type 1 diabetic patients unsatisfactorily controlled by Multiple Daily Injections (MDI). Few trials have explored CSII for basal-bolus therapy in type 2 diabetes...
Effect of combined secretagogue/biguanide treatment on mortality in type 2 diabetic patients with and without ischemic heart diseaseMatteo Monami
Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence, Florence, Italy
Int J Cardiol 126:247-51. 2008..The aim of this investigation was the assessment of the association of combined secretagogue/biguanide treatment with mortality in type 2 diabetic patients with and without ischemic heart disease (IHD)...
Dipeptydil peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trialsM Monami
Department of Critical Care Medicine, University of Florence and Azienda Ospedaliera Careggi, Florence, Italy
Nutr Metab Cardiovasc Dis 20:224-35. 2010..The role of Dipeptidyl Peptidase-4 (DPP-4) inhibitors in the treatment of type 2 diabetes is debated; many recent trials, which were not included in previous meta-analyses, could add relevant information...
Sulphonylureas and cancer: a case-control studyMatteo Monami
Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence and Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, 50134, Florence, Italy
Acta Diabetol 46:279-84. 2009..In particular, the possible protective effect of gliclazide, as well as the risk associated with glibenclamide, deserves further investigation...
Fasting and post-prandial glycemia and their correlation with glycated hemoglobin in Type 2 diabetesM Monami
Geriatric Unit, Department of Critical Care, University of Florence Medical School, 50141 Florence, Italy
J Endocrinol Invest 29:619-24. 2006..In the present study, we assessed the relationship with HbA1c of fasting and post-prandial glucose measured in a more naturalistic setting, through home glucose self-monitoring or with a continuous glucose monitoring system (CGM)...
Autologous skin fibroblast and keratinocyte grafts in the treatment of chronic foot ulcers in aging type 2 diabetic patientsMatteo Monami
Unit of Geriatric Medicine, Department of Cardiovascular Medicine, University of Florence and Azienda Ospedaliera Careggi, Florence, Italy
J Am Podiatr Med Assoc 101:55-8. 2011..we assessed the tolerability and efficacy of autologous skin cell grafts in older type 2 diabetic patients with chronic foot ulcers...
DPP-4 inhibitors and lipids: systematic review and meta-analysisMatteo Monami
Section of Geriatric Cardiology and Medicine, Department of Cardiovascular Medicine, Careggi, Teaching Hospital, Florence, Italy
Adv Ther 29:14-25. 2012..The present metaanalysis was designed to assess the effect of DPP-4 inhibitors on blood lipids, verifying possible differences across compounds of this class...
The diabetic person beyond a foot ulcer: healing, recurrence, and depressive symptomsMatteo Monami
Geriatric Unit, Department of Critical Care Medicine and Surgery, University of Florence and Careggi Hospital, Florence, Italy
J Am Podiatr Med Assoc 98:130-6. 2008..We specifically designed our study to assess the role of depressive symptoms in healing and recurrence of diabetic foot ulcers...
Glucagon-like peptide-1 receptor agonists and cardiovascular events: a meta-analysis of randomized clinical trialsMatteo Monami
Section of Geriatric Cardiology and Medicine, Department of Cardiovascular Medicine, University of Florence and Careggi Teaching Hospital, 50141 Florence, Italy
Exp Diabetes Res 2011:215764. 2011..This meta-analysis was designed to assess cardiovascular safety of GLP-1 receptor agonists...
Seizures as the only clinical manifestation of reactive hypoglycemia: a case reportM Monami
Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence and Azienda Ospedaliera Careggi, Via delle Oblate 4, 50139 Florence, Italy
J Endocrinol Invest 28:940-1. 2005..e., reactive hypoglycemia). To our knowledge, this is the first case ever reported of reactive hypoglycemia associated with Type 2 diabetes...
Metabolic syndrome and cardiovascular mortality in older type 2 diabetic patients: a longitudinal studyMatteo Monami
Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence and Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, 50134 Florence, Italy
J Gerontol A Biol Sci Med Sci 63:646-9. 2008..Although age does not seem to modify the association of the metabolic syndrome (MS) with cardiovascular risk in middle-aged individuals, no comparison of risks associated with MS between old and middle-aged persons has been reported so far...
Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) StudyMatteo Monami
Department of Critical Care Medicine and Surgery, Unit of Geriatrics, University of Florence and Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, 50134, Florence, Italy
Acta Diabetol 46:191-6. 2009..7). Elevated eGFR, estimated through methods which do not produce a systematic overestimate in obese subjects, is not associated with the diagnosis of MS, and does not predict diabetes...
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysisMatteo Monami
Section of Geriatric Cardiology, Department of Cardiovascular Medicine, Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, 50141 Florence, Italy
Acta Diabetol 47:77-81. 2010..Available data justify the use of CSII for basal-bolus insulin therapy in type 1 diabetic patients unsatisfactorily controlled with MDI...
Metabolic and cardiovascular outcomes of fatherhood: results from a cohort of study in subjects with sexual dysfunctionAlessandra D Fisher
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 9:2785-94. 2012..Up to now, no studies have evaluated these associations in a population of men seeking treatment for sexual dysfunction (SD)...
Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal studyGiovanni Corona
Andrology and Sexual Medicine Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 9:1669-80. 2012..The category of impaired fasting glucose (IFG) denotes a state of nondiabetic hyperglycemia, considered a risk factor for the further development of diabetes mellitus (DM) and cardiovascular (CV) diseases...
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) studyMatteo Monami
Geriatric Unit, Department of Critical Care and Surgery, University of Florence, Florence 50141, Italy
Metabolism 57:387-92. 2008..5-28.1]), but not diabetes. Elevated gamma-GT or AST is an independent predictor of CVD. An increase of gamma-GT levels above the reference range, or also in the upper reference range, is an independent predictor of incident diabetes...
Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunctionGiovanni Corona
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 7:1918-27. 2010....
Is obesity a further cardiovascular risk factor in patients with erectile dysfunction?Giovanni Corona
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 7:2538-46. 2010..Reduced penile blood flow is more common in obese people than in leaner ED subjects...
Priapus is happier with Venus than with BacchusValentina Boddi
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 7:2831-41. 2010..The relationship between alcohol consumption and erectile function is still not completely clarified...
Is metabolic syndrome a useless category in subjects with high cardiovascular risk? Results from a cohort study in men with erectile dysfunctionGiovanni Corona
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 8:504-11. 2011....
Prognostic value of serum liver enzymes levels in type 2 diabetic patientsMatteo Monami
Department of Critical Care Medicine and Surgery, Geriatric Medicine, University of Florence, Florence, Italy
Diabetes Metab Res Rev 23:625-30. 2007..Elevated liver enzymes are associated with cardiovascular disease, while their relationship with cancer-related mortality has not been assessed so far in diabetic patients...
Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunctionGiovanni Corona
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 7:1557-64. 2010....
Pulse pressure independently predicts major cardiovascular events in younger but not in older subjects with erectile dysfunctionGiovanni Corona
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 8:247-54. 2011..We previously also reported a negative association between PP and arteriogenic erectile dysfunction (ED). This finding has recently been questioned...
Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunctionGiovanni Corona
Sexual Medicine and Andrology Unit, University of Florence, Florence, Italy
J Sex Med 8:2098-105. 2011..Obesity is an independent cardiovascular (CV) risk factor. Testosterone (T) is inversely related to body mass index (BMI) in males. There is substantial evidence suggesting that low T could play a role as a moderator of CV mortality in men...
Poor response to alprostadil ICI test is associated with arteriogenic erectile dysfunction and higher risk of major adverse cardiovascular eventsGiulia Rastrelli
Sexual Medicine and Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 8:3433-45. 2011..Intracavernous alprostadil injection (ICI) test has been considered useless in assessing the vascular status of subjects with erectile dysfunction (ED)...
Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metforminMatteo Monami
Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence and Azienda Ospedaliera Vareggi, Via della Oblate 4, 50134 Florence, Italy
Diabetes Metab Res Rev 22:477-82. 2006..Safety of such combinations deserves further investigation...
Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patientsEdoardo Mannucci
Diabetes Agency, Careggi Teaching Hospital, Florence, Italy
Diabetes Care 33:1997-2003. 2010..Recent epidemiological studies suggested that some insulin analogues could be associated with increased risk of cancer. The present study is aimed at assessing the long-term association of different insulin analogues with cancer incidence...
Failure to metformin and insulin secretagogue monotherapy: an observational cohort studyLaura Pala
Section of Endocrinology, Department of Clinical Pathophysiology, University of Florence and Azienda Ospedaliera Careggi, Florence, Italy
Acta Diabetol 47:7-11. 2010..In conclusion, insulin secretagogues are associated with increased failure rate in comparison with metformin. This difference could be due to detrimental effect of secretagogues, rather than to a beneficial action of metformin...
Severe depressive symptoms and cardiovascular risk in subjects with erectile dysfunctionElisa Bandini
University of Florence Andrology Unit, Department of Clinical Physiopathology, Florence, Italy
J Sex Med 7:3477-86. 2010..Erectile dysfunction (ED) and mood depression are often associated and both are correlated with an increased risk of cardiovascular morbidity and mortality...
Left ventricular cavity obliteration during dobutamine stress echocardiography in diabetic patientsFrancesca Innocenti
Department of Critical Care Medicine and Surgery, Intensive Observation Unit, University of Florence and Azienda Ospedaliero Universitaria Careggi, Largo Brambilla 3, Florence, Italy
Int J Cardiovasc Imaging 28:1023-33. 2012....
Is the third component of metabolic syndrome really predictive of outcomes in type 2 diabetic patients?Matteo Monami
Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence and Azienda Ospedaliera Careggi, Via delle Oblate 4, 50134 Florence, Italy
Diabetes Care 29:2515-7. 2006
Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysisMatteo Monami
Geriatric Cardiology, Careggi Teaching Hospital and University of Florence, 50141 Florence, Italy
Exp Diabetes Res 2012:672658. 2012....
Metformin and cancer occurrence in insulin-treated type 2 diabetic patientsMatteo Monami
Section of Geriatric Cardiology and Medicine, Department of Cardiovascular Medicine, University of Florence and Careggi Teaching Hospital, Florence, Italy
Diabetes Care 34:129-31. 2011..Metformin is associated with reduced cancer-related morbidity and mortality. The aim of this study was to assess the effect of metformin on cancer incidence in a consecutive series of insulin-treated patients...
Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolismStefano Giannini
Section of Endocrinology, Department of Clinical Pathophysiology, University of Florence, Viale Pieraccini 6, 50134, Florence, Italy
J Clin Lipidol 6:132-8. 2012..The authors of large clinical trials in different ethnic groups highlighted the correlation between glycemia and lipid profile, although the effect of abdominal adiposity was not explored...
Winners and losers at the rosiglitazone gamble A meta-analytical approach at the definition of the cardiovascular risk profile of rosiglitazoneMatteo Monami
Section of Geriatric Cardiology, Department of Cardiovascular Medicine, Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, 50141 Florence, Italy
Diabetes Res Clin Pract 82:48-57. 2008..Benefits could outweigh harms in patients with poor glycemic control and worse lipid profile; conversely, the drug could increase the risk of MI in obese or insulin-treated patients...
Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertensionAndrea Ungar
University of Florence, Italy
J Am Geriatr Soc 57:291-6. 2009..To assess the relationship between office and ambulatory systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure (PP) and total mortality in elderly patients with hypertension...
Age and comorbidity in acute myocardial infarction: a report from the AMI-Florence Italian registryDaniela Balzi
Epidemiology Unit, Local Health Unit 10, Florence, Italy
Am J Geriatr Cardiol 15:35-41. 2006..Results confirm that although they might potentially benefit from CRT during ST-segment elevation myocardial infarction, older and frail patients are excluded from CRT, even when eligible...
Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trialsMatteo Monami
Diabetes Agency, University of Florence and Careggi Teaching Hospital, Florence, Italy
Diabetes Metab Res Rev 27:362-72. 2011..Available sub-group analysis of clinical trials does not allow a clear identification of predictors of therapeutic response to these drugs. The aim of this study is the assessment of predictors of response to DPP-4 inhibitors...
Effect of comorbidity on coronary reperfusion strategy and long-term mortality after acute myocardial infarctionDaniela Balzi
Epidemiology Unit, Local Health Unit 10, Florence, Italy
Am Heart J 151:1094-1100. 2006..This study was aimed at determining to what extent this effect is independent or derives from adoption of different therapeutic strategies...
Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trialsEdoardo Mannucci
Sections of Geriatric Cardiology, Department of Cardiovascular Medicine, University of Florence and AOU Careggi, Florence
Int J Cardiol 143:135-40. 2010..Aim of this analysis is the assessment of the cardiovascular risk with rosiglitazone, using a comprehensive data set...
Post-prandial glucose and diabetic complications: systematic review of observational studiesEdoardo Mannucci
Diabetes Agency, Department of Cardiovascular Medicine, Careggi Teaching Hospital, Azienda Ospedaliero Universitaria Careggi, via delle Oblate n 4, 50141, Florence, Italy
Acta Diabetol 49:307-14. 2012....
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic studyGiovanni Corona
Sexual Medicine and Andrology Unit, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
Eur J Endocrinol 165:687-701. 2011..To verify whether hypogonadism represents a risk factor for cardiovascular (CV) morbidity and mortality and to verify whether testosterone replacement therapy (TRT) improves CV parameters in subjects with known CV diseases (CVDs)...
Testosterone and metabolic syndrome: a meta-analysis studyGiovanni Corona
Andrology and Sexual Medicine Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 8:272-83. 2011..Metabolic syndrome (MetS) is often associated with male hypogonadism. Despite the well-known link, the role of testosterone replacement therapy (TRT) in MetS has not been completely clarified...
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trialsMatteo Monami
Unit of Geriatric Medicine, Department of Critical Care Medicine, University of Florence and Azienda Ospedaliera Careggi, Florence, Italy
Eur J Endocrinol 160:909-17. 2009..The role of glucagon-like peptide-1 (GLP-1) receptor agonists in the treatment of type 2 diabetes is debated; many recent trials, which were not included in previous meta-analyses, could add relevant information...
All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanidesEdoardo Mannucci
Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence, Florence, Italy
Diabetes Metab Res Rev 20:44-7. 2004..This study was aimed at the assessment of mortality in patients treated with low-dose combinations of sulfonylureas and biguanides...
Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunctionGiovanni Corona
Sexual Medicine and Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy Endocrinology Unit, Medical Department, Azienda USL, Maggiore Bellaria Hospital, Bologna, Italy
J Sex Med 10:1074-89. 2013..Reduced libido is a symptom referring more to a reduction in sexual drive for sexual activity...
Rosiglitazone and risk of cancer: a meta-analysis of randomized clinical trialsMatteo Monami
Department of Cardiovascular Medicine, Section of Geriatric Cardiology, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
Diabetes Care 31:1455-60. 2008..The aim of this meta-analysis of randomized clinical trials is to assess the effect of rosiglitazone on the incidence of cancer...
Sexual and cardiovascular correlates of male unfaithfulnessAlessandra D Fisher
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 9:1508-18. 2012..Therefore, the study of this sensitive topic is extremely complex, and its prevalence is often underestimated...
Pulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort studyEdoardo Mannucci
Geriatric Unit, Department of Critical Care, University of Florence Medical School, Florence, Italy
Diabetes Metab Res Rev 22:172-5. 2006..An association between office PP and cardiovascular mortality has been previously reported in diabetic patients, while the relationship between ambulatory measurements of PP and all-cause mortality has not been assessed so far...
Incidence and prognostic significance of hypoglycemia in hospitalized non-diabetic elderly patientsEdoardo Mannucci
Department of Critical Care and Surgery, Unit of Gerontology and Geriatrics, University of Florence, and Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, 50141 Florence, Italy
Aging Clin Exp Res 18:446-51. 2006..To assess the incidence and prognostic value of hypoglycemia in hospitalized non-diabetic elderly patients...
Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadismGiovanni Corona
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 6:2591-600. 2009..Couple sexual dysfunction is a common, but not often studied, problem...
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysisGiovanni Corona
Sexual Medicine Andrology Unit, Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy
Eur J Endocrinol 168:829-43. 2013..The aim of this study is to perform a systematic review and meta-analysis of available trials on the effect of body weight loss on sex hormones levels...
The Identification of Prediabetes Condition with ARIC Algorithm Predicts Long-Term CV Events in Patients with Erectile DysfunctionGiovanni Corona
Sexual Medicine and Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy Endocrinology Unit, Medical Department, Azienda USL, Maggiore Bellaria Hospital, Bologna, Italy
J Sex Med 10:1114-23. 2013..Recently, it has been shown to predict another relevant cardiovascular (CV) risk factor, such as chronic kidney disease...
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trialsMatteo Monami
Section of Geriatric Cardiology and Medicine, Department of Cardiovascular Medicine, University of Florence and Careggi Teaching Hospital, Florence, Italy
Curr Med Res Opin 29:369-78. 2013..The aim of the present paper is to provide some further data on the relationship between β-blocker treatment and the incidence of cancer, using two different approaches (epidemiological study and meta-analysis of clinical trials)...
Adiponectin, diabetes and ischemic heart failure: a challenging relationshipSamuele Baldasseroni
Department of Critical Care Medicine and Surgery, Geriatric Medicine Unit, University of Florence, Florence, Italy
Cardiovasc Diabetol 11:151. 2012..We evaluated the level of adiponectin in patients with ischemic HF, with and without type 2 diabetes, to elucidate whether the metabolic syndrome was able to influence the relationship between AD and HF...
Prognostic value of dobutamine stress echocardiography in diabetic patientsFrancesca Innocenti
Department of Critical Care Medicine and Surgery, University of Florence and Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 1, 50141, Florence, Italy
Int J Cardiovasc Imaging 26:499-507. 2010..245, CI: 1.503-7.005, P = 0.003). In diabetic patients with known or suspected CAD, presence of viability and severe ischemia during DSE are independently associated with higher occurrence of hard cardiac events...
Adipokines as possible new predictors of cardiovascular diseases: a case control studyLaura Pala
SOD of Endocrinology, AOUC, 50139 Florence, Italy
J Nutr Metab 2012:253428. 2012..The present study confirms that low adiponectin is associated with increased incidents of IHD, but not CVD, and suggests, for the first time, a major effect of visfatin, aFABP, and RBP4 in the development of cardiovascular disease...
Metformin beyond diabetes: new life for an old drugCarlo M Rotella
Endocrinology Unit, Department of Clinical Pathophysiology, University of Florence Medical School, Florence, Italy
Curr Diabetes Rev 2:307-15. 2006....
Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective studyFrancesco Rotella
Diabetes Agency, Careggi Teaching Hospital and University of Florence, Largo Brambilla 3, 50134 Florence, Italy
Acta Diabetol 49:S179-84. 2012..These areas should be adequately explored for obtaining an overall picture of the psychological determinants of appropriate metabolic control in diabetes...
Resistin level in coronary artery disease and heart failure: the central role of kidney functionSamuele Baldasseroni
Department of Critical Care Medicine and Surgery, University of Florence and Azienda Ospedaliero Universitaria Careggi, Viale Morgagni 85, Florence, Italy
J Cardiovasc Med (Hagerstown) 14:150-7. 2013..The aim of this study was to evaluate resistin levels in patients with coronary artery disease (CAD) with or without chronic heart failure, in order to define its independent predictor...
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysisMatteo Monami
Section of Geriatric Cardiology, Department of Cardiovascular Medicine, Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, 50141 Florence, Italy
Diabetes Res Clin Pract 81:184-9. 2008..Aim of the present meta-analysis is the assessment of differences with respect to HbA1c, incidence of hypoglycaemia, weight gain, between NPH human insulin and each long-acting analogue...
[Psychological disorders and cardiovascular diseases]Matteo Monami
Unità Funzionale di Gerontologia e Geriatria, Dipartimento di Area Critica Medico Chirurgica, Universita degli Studi, Azienda Ospedaliero Universitaria Careggi, Firenze
G Ital Cardiol (Rome) 8:335-48. 2007....
Is the evidence from clinical trials for cardiovascular risk or harm for glitazones convincing?Edoardo Mannucci
Department of Cardiovascular Medicine, Section of Geriatric Cardiology, Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, 50141 Florence, Italy
Curr Diab Rep 9:342-7. 2009..This article reviews the available clinical evidence on the cardiovascular effects of TZDs, discussing possible mechanisms underlying the observed effects and suggesting some directions for future research...
Calcium channel blockers and nephroprotectionAndrea Ungar
Unit of Gerontology and Geriatric Medicine, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy
Aging Clin Exp Res 17:31-9. 2005..This paper reviews the main pathophysiological aspects of renal damage in hypertension, the effects of various types of calcium channel blockers (CCBs) on renal function, and their role in nephroprotection...
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patientsE Mannucci
Section of Geriatric Cardiology, Department of Critical Care Medicine and Surgery, University of Florence and Azienda Ospedaliero Universitaria Careggi, 50134 Florence, Italy
J Endocrinol Invest 33:147-50. 2010..This study is aimed at the assessment of the relationship between meal-induced GLP-1 and post-prandial hyperglycemia in Type 2 diabetic patients...
Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysisE Mannucci
Department of Cardiovascular Medicine, Section of Geriatric Cardiology, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
Diabetes Obes Metab 11:53-9. 2009..Short-acting insulin analogues, in comparison with regular human insulin (HRI), provide a greater control of postprandial glucose, while their superiority on haemoglobin A1c (HbA1c) is controversial...
Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trialsMatteo Monami
Section of Geriatric Cardiology and Medicine, Department of Cardiovascular Medicine, Careggi Teaching Hospital, Florence, Italy
Curr Med Res Opin 27:57-64. 2011..The aim of the present meta-analysis of randomized clinical trials is the assessment of the effect of DPP4i on the incidence of major cardiovascular events (MACE), cancer, and pancreatitis...
Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trialsMatteo Monami
Section of Geriatric Cardiology and Medicine, Department of Cardiovascular Medicine, Careggi Teaching Hospital, Florence, Italy
Diabetes Care 34:2474-6. 2011..Incretin hormones increase bone density in experimental models, but the effect of dipeptidyl peptidase-4 (DPP-4) inhibitors on bone fractures has not been reported so far...
Glucagon-like peptide-1, diabetes, and cognitive decline: possible pathophysiological links and therapeutic opportunitiesEnrico Mossello
Unit of Gerontology and Geriatric Medicine, Department of Critical Care Medicine and Surgery, University of Florence and Careggi Teaching Hospital, 50121 Florence, Italy
Exp Diabetes Res 2011:281674. 2011..Drug treatments enhancing GLP-1 activity hold out hope for treatment and prevention of Alzheimer's disease (AD) and cognitive decline...
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort studyM Monami
Department of Critical Care Medicine and Surgery, Unit of Geriatrics, University of Florence, Florence, Italy
Exp Clin Endocrinol Diabetes 116:184-9. 2008..Recent evidence suggests that some hypoglycemic treatments could affect the incidence of malignancies. This study was aimed at the assessment of cancer-related mortality in type 2 diabetic patients treated with different hypoglycemic drugs...
How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR studyE Mannucci
Section of Endocrinology, Department of Clinical Pathophysiology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
Nutr Metab Cardiovasc Dis 17:719-26. 2007..Factor analysis can be used as a basis for the determination of diagnostic criteria for the metabolic syndrome (MS). This approach can be used as a basis for the determination of diagnostic criteria for MS...
Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysisM Monami
Unit of Geriatrics, Department of Cardiovascular Medicine, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
Diabetes Obes Metab 11:372-8. 2009..Aim of this meta-analysis is the assessment of differences with respect to HbA1c (Glycated hemoglobin), incidence of hypoglycaemia, and weight gain, between NPH human insulin and each long-acting analogue...
IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patientsM Monami
Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence, Florence, Italy
Diabetes Obes Metab 9:350-3. 2007..The aim of the present study was to assess the prognostic value of IDF criteria in diabetic patients, in comparison with previous ATP-III criteria...
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli studyE Mannucci
Diabetes Section, Geriatric Unit, Department of Critical Care, University of Florence, Florence, Italy
Diabetes Obes Metab 10:430-5. 2008..Aim of the present investigation is to compare the predictive value for diabetes of NCEP and IDF definitions of MS in a large sample of predominantly Caucasian subjects...
National Cholesterol Educational Program and International Diabetes Federation diagnostic criteria for metabolic syndrome in an Italian cohort: results from the FIBAR StudyE Mannucci
Section of Endocrinology, Department of Clinical Pathophysiology, University of Florence, Florence, Italy
J Endocrinol Invest 30:925-30. 2007..Few data are available in Caucasian non-diabetic subjects...
Age-related changes in treatment strategies for acute myocardial infarction: a population-based studyAlessandro Barchielli
Epidemiology Unit, Azienda Sanitaria di Firenze, Florence, Italy
J Am Geriatr Soc 52:1355-60. 2004..To compare across four age groups (<65, 65-74, 75-84, > or =85) the determinants of coronary reperfusion therapy (CRT) use in ST-segment elevation acute myocardial infarction (STE-AMI)...
Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunctionGiovanni Corona
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Florence, Italy
J Sex Med 6:1457-66. 2009..The physiological role of prolactin (PRL) in male sexual behavior is poorly understood. Conversely, the association between PRL pathological elevation in both reproductive and sexual behavior is well defined...
Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortalityM Monami
Geriatric Unit, Department of Critical Care, University of Florence Medical School, Florence, Italy
Diabetes Metab Res Rev 23:479-84. 2007..Aim of the present study is the comparison of all-cause, cardiovascular and non-cardiovascular mortality, and cardiac morbidity, between patients treated with glibenclamide and gliclazide...
Metabolic syndrome and pulse pressureE Mannucci
Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence, Florence, Italy
Diabetes Obes Metab 9:600-2. 2007..Aim of the present study is to verify the association of high PP with metabolic syndrome (MS) and with its individual components...
Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trialsE Mannucci
Department of Cardiovascular Medicine, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy
Diabetes Obes Metab 10:1221-38. 2008..The aim of this meta-analysis of randomized clinical trials (RCT) was to assess whether pioglitazone is also associated with increased cardiovascular risk, as recently reported for rosiglitazone...
Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trialsE Mannucci
Section of Geriatric Cardiology, Department of Cardiovascular Medicine, Azienda Ospedaliero Universitaria Careggi, Via delle Oblate 4, 50141 Florence, Italy
Nutr Metab Cardiovasc Dis 19:604-12. 2009..Aim of this meta-analysis is the assessment of the effects of improvement of glycemic control on the incidence of cardiovascular diseases in patients with type 2 diabetes...
Isolated ambulatory hypertension is common in outpatients referred to a hypertension centreA Ungar
Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics Hypertension Centre, University of Florence, and Azienda Ospedaliera Careggi, Florence, Italy
J Hum Hypertens 18:897-903. 2004..These findings suggest that isolated ambulatory hypertension is very common and probably the indications for ABPM should be more extensive in outpatients referred to hypertensive centre...
Indexes of abdominal adiposity in patients with type 2 diabetesE Mannucci
Department of Critical Care, University of Florence, Florence, Italy
J Endocrinol Invest 27:535-40. 2004..To assess the relationship of waist circumference and weight/height ratio with height, and their association with components of the metabolic syndrome, in Type 2 diabetic patients...
Management of acute myocardial infarction in the real world: a summary report from The Ami-Florence Italian RegistryDaniela Balzi
Epidemiology Unit, Azienda Sanitaria Firenze, Viale Michelangelo 41, 50125 Florence, Italy
Intern Emerg Med 3:109-15. 2008..These results suggest the need for interdisciplinary reassessing the adherence to therapeutic guidelines and the criteria adopted in the real clinical world to select patients for CRT during STEMI...
Use of an oxidized regenerated cellulose and collagen composite for healing of chronic diabetic foot ulcers: a report of two casesMatteo Monami
Diabetes Care 25:1892-3. 2002
Rosiglitazone and cardiovascular riskEdoardo Mannucci
N Engl J Med 357:938; author reply 939-40. 2007
Finger sepsis in two poorly controlled diabetic patients with reuse of lancetsMatteo Monami
Diabetes Care 25:1103. 2002
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesEdoardo Mannucci
Diabetes Care 30:193-4. 2007
